Lineage Cell Therapeutics Inc (LCTX)

07:29 AM

How does Lineage Cell Therapeutics Inc. compare to its industry peersBuild wealth faster with consistent growth stocks - jammulinksnews.com

07:29 AM

Jul 25, 2025

Is Lineage Cell Therapeutics Inc. a good long term investmentFree Smart Trading Workshop - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

Lineage Cell Therapeutics Inc. Stock Analysis and ForecastTremendous growth opportunities - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

What analysts say about Lineage Cell Therapeutics Inc. stockPhenomenal investment performance - PrintWeekIndia

Jul 25, 2025

Jul 23, 2025

What drives Lineage Cell Therapeutics Inc. stock priceFree Consultation - Autocar Professional

Jul 23, 2025

Jul 16, 2025

Stem Cell Therapy Market Attracts Investment in Neuro, Onco & - openPR.com

Jul 16, 2025

Jul 15, 2025

Why Lineage Cell Therapeutics Inc. stock attracts strong analyst attentionHigh Return Conservative Stocks - Newser

Jul 15, 2025

Jul 15, 2025

What makes Lineage Cell Therapeutics Inc. stock price move sharplyFree Stock Market Practical Discussion Forums - Newser

Jul 15, 2025

Jul 15, 2025

How Lineage Cell Therapeutics Inc. stock performs during market volatilityBreakout Momentum Stocks - Newser

Jul 15, 2025

Jul 14, 2025

Spinal Cord Injury Pipeline 2025: MOA And ROA Insights, Clinical Trials Status, And Key Companies Involved By Delveinsight Stemcyte, Nervgen Pharma, VA Office Of Research And Development, Kessler - MenaFN

Jul 14, 2025

Jul 11, 2025

Cell Therapy Manufacturing Market Exclusive Report with - openPR.com

Jul 11, 2025

Jul 03, 2025

Cell Therapy Manufacturing Market In-depth Insights, Business - openPR.com

Jul 03, 2025

Jul 02, 2025

Lineage Cell Therapeutics shareholders approve board slate and equity plan amendment - Investing.com

Jul 02, 2025

Jun 23, 2025

Lineage Cell stock holds steady as Roche presents positive 3-year data - Investing.com UK

Jun 23, 2025

Jun 20, 2025

Lineage Cell Therapeutics (LCTX) Drops 1.65% Amid OpRegen Trial Hype - AInvest

Jun 20, 2025

Jun 13, 2025

Two Sigma Investments LP Buys New Shares in Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) - Defense World

Jun 13, 2025

Jun 11, 2025

Rising Demand in Allogeneic Stem Cells Market USD 2.0Bn By 2031 - openPR.com

Jun 11, 2025

Jun 11, 2025

Squarepoint Ops LLC Takes $46,000 Position in Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) - Defense World

Jun 11, 2025

Jun 10, 2025

Cell Therapy Manufacturing Market Exclusive Report with Detailed Study Analysis | WuXi AppTec, Healios Ltd. - newstrail.com

Jun 10, 2025

Jun 09, 2025

Lineage Cell Therapeutics appoints new auditor - Investing.com Australia

Jun 09, 2025

Jun 09, 2025

Two Sigma Advisers LP Has $44,000 Holdings in Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) - Defense World

Jun 09, 2025

Jun 08, 2025

Jane Street Group LLC Buys 142,965 Shares of Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) - Defense World

Jun 08, 2025

Jun 05, 2025

Lineage Cell Therapeutics Announces Updates to the 3rd Annual Spinal Cord Injury Investor Symposium - BioSpace

Jun 05, 2025